Skip to content

MOLN

Molecular Partners AG

NASDAQ · Healthcare · Biotechnology · CH

$3.66
+2.81%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-98.2%
Return on equity
-75.9%
Return on assets
-94.1%
Return on invested capital
0.00x
Asset turnover
-$62.6M
Cash from operations
$2.15
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026